Search
for
Sort by
Research 301–330 of 782
- Case Report: Pulsed electric field treatment of metastatic liver disease demonstrating a possible abscopal response
- Mucocutaneous reactions to chemotherapy
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- Efficacy of interventions for prevention of chemotherapy‐induced alopecia: A systematic review and meta‐analysis
- Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women’s cancers. Results of a prospective study
- CDK4/6 inhibition mitigates stem cell damage in a novel model for taxane‐induced alopecia
- Side effects of CHOP in the treatment of non-Hodgkin's lymphoma
- Scalp hypothermia as a preventative measure for chemotherapy‐induced alopecia: a review of controlled clinical trials
- The use of minoxidil to attempt to prevent alopecia during chemotherapy for gynecologic malignancies.
- Assessing the cost-effectiveness of DNA origami nanostructures for targeted delivery of anti-cancer drugs to tumours
- Results of scalp cooling during anthracycline containing chemotherapy depend on scalp skin temperature
- p53 Is a Direct Transcriptional Repressor of Keratin 17: Lessons from a Rat Model of Radiation Dermatitis
- Scalp cooling to prevent chemotherapy-induced alopecia
- Prophylaxis and Management of Skin Toxicities
- Management of Dermatologic Toxicities
- Genetic analysis of a novel antioxidant multi-target iron chelator, M30 protecting against chemotherapy-induced alopecia in mice
- Suppression of eukaryotic initiation factor 4E prevents chemotherapy-induced alopecia
- A weighted non-negative matrix factorization approach to predict potential associations between drug and disease
- 17-Oximino-5-androsten-3β-yl esters: synthesis, antiproliferative activity, acute toxicity, and effect on serum androgen level
- Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer
- Taxane-induced alopecia: A historical review of patients with ovarian or breast cancer treated with with paclitaxel, docetaxel or paclitaxel poliglumex
- Hidradenitis secondary to nirogacestat, a recently approved desmoid tumor medication
- The financial burden of scalp cooling therapy: A nonprofit organization data analysis
- Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?
- The effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
- The utility of DHL-HisZnNa, a novel antioxidant, against anticancer agent-induced alopecia in breast cancer patients: a multicenter phase II clinical trial
- Quality of Life of Patients with Metastatic Breast Cancer Treated with Epirubicin and Docetaxel
- Formulation of Deformable Liponiosomal Hybrid of Repaglinide: In vitro Characterization and Evaluation of the Anti-Diabetic Effect
- Sodium Valproate-Induced Hyperpigmentation
- Protection from ifosfamide-induced alopecia by topical thiols in young rats